George Winn - Electromed Vice Chairman of the Board

<div class='circular--portrait' style='background:#689CFD;color: #ffffff;font-size:4em;padding-top: 25px;;'>EL</div>
ELMD -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

Dr. George H. Winn DDS serves as a Vice Chairman of the Board and an Independent Director of the Company. He has served on the Board since 2005 and served as its Vice Chairman from May 2012 through November 2014. He has practiced dentistry with an emphasis in orthodontics and facial pain management in New Prague, Minnesota, for over 50 years. He holds a Bachelor of Arts from Mankato State College, a BS from the University of Minnesota and a D.D.S. from the University of Minnesota School of Dentistry. He has served as an associate clinical professor in the Department of Operative Dentistry and participates in a medical ethics program of the American College of Dentists at the University of Minnesota School of Dentistry
Age: 80  Chairman Since 2017  Ph.D    
952 758 9299
Winn previously served for nine years on the University of Minnesota Foundation Board of Trustees, which included service on its executive and finance committees, from 2007 through 2016. Among other attributes, skills, experiences and qualifications, our Board believes that, in addition to the vast industry relationships that Dr. Winn has developed, his education and experience give him insight into the medical device industry that is valuable in his role as a director.

Electromed Management Efficiency

Electromed has return on total asset (ROA) of 0.0716 % which means that it generated profit of $0.0716 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 0.0696 % meaning that it created $0.0696 on every $100 dollars invested by stockholders. Electromed management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. As of June 5, 2020, Return on Average Assets is expected to decline to 0.0007. In addition to that, Return on Average Equity is expected to decline to 0.0007Electromed Asset Turnover is expected to slightly increase based on the last few years of reporting. The last year's Asset Turnover was at 1.29. Electromed Liabilities Non Current is expected to significantly decrease based on the last few years of reporting. The last year's Liabilities Non Current was at 13,263.3
The company currently holds 122.57 K in liabilities with Debt to Equity (D/E) ratio of 0.4 which is about average as compared to similar companies. Electromed has Current Ratio of 8.6 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 6 records


Kelvyn CullimoreDynatronics
Philippe ChauveauEDAP TMS SA
Alfred MannSecond Sight Medical
Michael MussallemEdwards Lifesciences Corporatio
Jeffrey EberweinDigirad

Company Summary

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of all ages in the United States and internationally. The company was founded in 1992 and is headquartered in New Prague, Minnesota. Electromed operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 119 people.Electromed (ELMD) is traded on BATS Exchange in USA. It is located in 500 Sixth Avenue NW and employs 119 people. Electromed is listed under Medical Equipment category by Fama And French industry classification.

Electromed Leadership Team

Kathleen Skarvan, CEO and President and Director
George Winn, Vice Chairman of the Board
Thomas Hagedorn, Independent Director
Stephen Craney, Independent Chairman of the Board
Stan Erickson, Independent Director
William Eckles, Independent Director
Jeremy Brock, CFO
Lee Jones, Director

Stock Performance Indicators

Did you try this?

Run Pattern Recognition Now


Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Electromed Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Electromed and Edwards Lifesciences. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Investing Opportunities. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page